Amylyx gets first approval for ALS drug from Canada

Amylyx gets first approval for ALS drug from Canada

Source: 
Yahoo/Reuters
snippet: 

Canada has approved Amylyx Pharmaceuticals' treatment for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease, the drugmaker said on Monday, the first such approval for the oral drug.